These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 32486357

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Identification of protein-protein interactions of human HtrA1.
    Campioni M, Severino A, Manente L, De Luca A, La Porta R, Vitiello A, Fiore P, Toldo S, Spugnini EP, Paggi MG, Baldi A.
    Front Biosci (Elite Ed); 2011 Jun 01; 3(4):1493-9. PubMed ID: 21622153
    [Abstract] [Full Text] [Related]

  • 43. Pattern of expression of HtrA1 during mouse development.
    De Luca A, De Falco M, De Luca L, Penta R, Shridhar V, Baldi F, Campioni M, Paggi MG, Baldi A.
    J Histochem Cytochem; 2004 Dec 01; 52(12):1609-17. PubMed ID: 15557215
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. MSI-L/EMAST is a predictive biomarker for metastasis in colorectal cancer patients.
    Torshizi Esfahani A, Seyedna SY, Nazemalhosseini Mojarad E, Majd A, Asadzadeh Aghdaei H.
    J Cell Physiol; 2019 Aug 01; 234(8):13128-13136. PubMed ID: 30549036
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. HtrA1 suppresses the growth of pancreatic cancer cells by modulating Notch-1 expression.
    Cheng H, Zhu H, Cao M, Lu C, Bao S, Pan Y.
    Braz J Med Biol Res; 2018 Nov 23; 52(1):e7718. PubMed ID: 30484491
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Mitochondrial DNA alteration in primary and metastatic colorectal cancer: Different frequency and association with selected clinicopathological and molecular markers.
    Kleist B, Meurer T, Poetsch M.
    Tumour Biol; 2017 Mar 23; 39(3):1010428317692246. PubMed ID: 28345467
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Deciphering Elevated Microsatellite Alterations at Selected Tetra/Pentanucleotide Repeats, Microsatellite Instability, and Loss of Heterozygosity in Colorectal Cancers.
    Wang Y, Vnencak-Jones CL, Cates JM, Shi C.
    J Mol Diagn; 2018 May 23; 20(3):366-372. PubMed ID: 29474982
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Frameshift mutations of poly(adenosine diphosphate-ribose) polymerase genes in gastric and colorectal cancers with microsatellite instability.
    Kim MS, An CH, Kim SS, Yoo NJ, Lee SH.
    Hum Pathol; 2011 Sep 23; 42(9):1289-96. PubMed ID: 21333322
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.